Clinical Trial Update: Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial of lapatinib with radiation for stage III-IV head and neck squamous cell carcinoma in patients unable to tolerate concurrent chemotherapy; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Quynh-Thu Le | Conditions: Head and Neck Cancer, Carcinoma, Squamous Cell | Phase 2 | Status: TERMINATED | Results posted: 2017-03-06